Penny Lovat

Person

Newcastle upon Tyne, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Monoclonal antibodies against Ambra-1
- Patent number 12,275,780
- Issue date Apr 15, 2025
- AMLO Biosciences Limited
- Penny Lovat
- G01 - MEASURING TESTING
Information Patent Grant
Ambra-1 and Loricrin as biomarkers for disease progression in melanoma
- Patent number 10,634,678
- Issue date Apr 28, 2020
- AMLO Biosciences Limited
- Marie Labus
- G01 - MEASURING TESTING
Information Patent Grant
Skin model
- Patent number 10,408,848
- Issue date Sep 10, 2019
- Alcyomics LTD
- Penny Lovat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BIOMARKERS FOR DISEASE PROGRESSION AND/OR RECURRENCE IN SQUAMOUS CE...
- Publication number 20250189528
- Publication date Jun 12, 2025
- AMLO Biosciences Limited
- Penny LOVAT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CLINICAL MANAGEMENT OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
- Publication number 20220412976
- Publication date Dec 29, 2022
- AMLO Biosciences Limited
- Penny LOVAT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS FOR DISEASE PROGRESSION IN SQUAMOUS CELL CARCINOMA
- Publication number 20220308059
- Publication date Sep 29, 2022
- AMLO Biosciences Limited
- Marie LABUS
- G01 - MEASURING TESTING
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST LORICRIN
- Publication number 20210396758
- Publication date Dec 23, 2021
- AMLO Biosciences Limited
- Penny LOVAT
- G01 - MEASURING TESTING
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST AMBRA-1
- Publication number 20210324059
- Publication date Oct 21, 2021
- AMLO Biosciences Limited
- Penny LOVAT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS FOR DISEASE PROGRESSION IN MELANOMA
- Publication number 20200018756
- Publication date Jan 16, 2020
- AMLO Biosciences Limited
- Marie Labus
- G01 - MEASURING TESTING
Information Patent Application
BIOMARKERS FOR DISEASE PROGRESSION IN MELANOMA
- Publication number 20180196050
- Publication date Jul 12, 2018
- UNIVERSITY OF NEWCASTLE UPON TYNE
- Marie Labus
- G01 - MEASURING TESTING
Information Patent Application
SKIN MODEL
- Publication number 20160320419
- Publication date Nov 3, 2016
- Alcyomics Ltd
- Penny Lovat
- G01 - MEASURING TESTING
Information Patent Application
SKIN MODEL
- Publication number 20160003856
- Publication date Jan 7, 2016
- Alcyomics Ltd
- Penny Lovat
- G01 - MEASURING TESTING

Penny Lovat

Person

Patents Grantslast 30 patents

Monoclonal antibodies against Ambra-1

Ambra-1 and Loricrin as biomarkers for disease progression in melanoma

Skin model

Patents Applicationslast 30 patents

BIOMARKERS FOR DISEASE PROGRESSION AND/OR RECURRENCE IN SQUAMOUS CE...

CLINICAL MANAGEMENT OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

BIOMARKERS FOR DISEASE PROGRESSION IN SQUAMOUS CELL CARCINOMA

MONOCLONAL ANTIBODIES AGAINST LORICRIN

MONOCLONAL ANTIBODIES AGAINST AMBRA-1

BIOMARKERS FOR DISEASE PROGRESSION IN MELANOMA

BIOMARKERS FOR DISEASE PROGRESSION IN MELANOMA

SKIN MODEL

SKIN MODEL